Purple Biotech Ltd.

PPBT66

Penny Stock

$2.19arrow_drop_down14.17%-$0.35

Penny Stock

PPBT66

$2.19

arrow_drop_down14.17%-$0.35

Penny Stock

Performance History

Key Stats
Open	$2.48
Prev. Close	$2.54
EPS	81.00
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-
Market Cap	$3.42M

	LOW	HIGH
Day Range	2.16	2.79
52 Week Range	2.16	36.00

Ratios

Revenue	-



EBITDA Margin %	-

EPS	81.00

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About Purple Biotech Ltd. (PPBT)

Purple Biotech Ltd. (PPBT) is a biotechnology company that focuses on the development and commercialization of novel therapies for the treatment of cancer. With a strong commitment to innovation, Purple Biotech is dedicated to improving the lives of patients and advancing the field of oncology. The company's stock price history reflects its growth and potential in the industry. Investors have shown confidence in Purple Biotech's ability to deliver groundbreaking therapies, leading to an increase in its stock price over time.

Purple Biotech Ltd. (PPBT) is traded under the ticker symbol PPBT. The company's stock quote is an important tool for investors and analysts to assess its current value in the market. Whether they are monitoring the stock for potential investment opportunities or tracking its performance, the stock quote provides essential information about Purple Biotech's financial standing. By analyzing the stock quote, investors can make informed decisions about buying or selling Purple Biotech shares.

Websitecall_made

Sector: Healthcare
Industry: Biotechnology
CEO: Mr. Isaac Israel
Headquarters: Rehovot
Employees: 20
Exchange: NASDAQ

Keep an eye on Purple Biotech Ltd.

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is Purple Biotech Ltd.'s (PPBT) price per share?

The current price per share for Purple Biotech Ltd. (PPBT) is $2.19. The stock has seen a price change of -$0.36 recently, indicating a -14.17% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for Purple Biotech Ltd. (PPBT)?

For Purple Biotech Ltd. (PPBT), the 52-week high is $36, which is 1.54K% from the current price. The 52-week low is $2.16, the current price is 1.39% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is Purple Biotech Ltd. (PPBT) a growth stock?

Purple Biotech Ltd. (PPBT) has shown an average price growth of -4.13% over the past three years. It has received a score of 56 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Purple Biotech Ltd. as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is Purple Biotech Ltd. (PPBT) stock price performance year to date (YTD)?

As of the latest data, Purple Biotech Ltd. (PPBT) has a year-to-date price change of -85.79%. Over the past month, the stock has experienced a price change of -54.37%. Over the last three months, the change has been -72.62%. Over the past six months, the figure is -86.31%.

help

Is Purple Biotech Ltd. (PPBT) a profitable company?

Purple Biotech Ltd. (PPBT) has a net income of -$19.88M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 0% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , with a revenue growth rate of 100%, providing insight into the company's sales performance and growth. Operating income is noted at $22.27M. Furthermore, the EBITDA is -$19.62M.

help

What is the market capitalization of Purple Biotech Ltd. (PPBT)?

Purple Biotech Ltd. (PPBT) has a market capitalization of $3.43M. The average daily trading volume is 2.39, indicating the stock's liquidity and investor engagement.

News

Purple Biotech Reports Third Quarter 2024 Financial Results

Purple Biotech Identifies Potential New Serum Biomarker for its Lead Oncology Therapeutic Candidate CM24: Associated with 79% Reduction in Risk of Death

PURPLE BIOTECH

H.C. WAINWRIGHT

INVESTMENT CONFERENCE

TUMOR IMMUNE EVASION

DRUG RESISTANCE

Aug 30, 2024

Purple Biotech to Participate at H.C. Wainwright 26th Annual Global Investment Conference

PRESS RELEASES

WARRANTS AND CERTIFICATES

Jul 1, 2024

Purple Biotech Announces Exercise of Warrants for $2 Million Gross Proceeds

PRESS RELEASES

HEALTH

CLINICAL STUDY

CONFERENCE CALLS/ WEBCASTS

Jun 27, 2024

Purple Biotech Reports Additional Positive Interim Results from its Randomized Phase 2 Pancreatic Cancer Study with CM24 Regarding a Potential Predictive Biomarker for Overall Survival Benefit

PRESS RELEASES

COMPANY ANNOUNCEMENT

Jun 1, 2024

Purple Biotech Announces Positive Late-Breaking Interim Randomized Phase 2 Data at ASCO 2024 Demonstrating CM24 Improved Overall Survival and other Efficacy Endpoints in Pancreatic Cancer

Performance History

Score Breakdown

Welcome to Stocklytics

Analyst Forecast

Analyst Ratings

About Purple Biotech Ltd. (PPBT)

Keep an eye on Purple Biotech Ltd.

Frequently Asked Questions

What is Purple Biotech Ltd.'s (PPBT) price per share?

What is the 52-week high and low for Purple Biotech Ltd. (PPBT)?

Is Purple Biotech Ltd. (PPBT) a growth stock?

What is Purple Biotech Ltd. (PPBT) stock price performance year to date (YTD)?

Is Purple Biotech Ltd. (PPBT) a profitable company?

What is the market capitalization of Purple Biotech Ltd. (PPBT)?

News

Take Your Investments to a Whole New Level